Login
EN
[EN] English
[FR] Français
Login
EN
[EN] English
[FR] Français
Give us feedback
Explore
Search
Special collections
Statistics
News
Help
Start on ORBi
Deposit
Profile
Publication List
Add your ORCID
Tutorials
Legal Information
Training sessions
About
What's ORBi ?
Impact and visibility
Around ORBi
About statistics
About metrics
OAI-PMH
ORBi team
Release Notes
Back
Home
Detailled Reference
Request a copy
Article (Scientific journals)
L'ipilimumab, un progrès significatif dans le traitement du mélanome métastatique
Libon, Florence
;
RORIVE, Andrée
;
NIKKELS, Arjen
2011
•
In
Skin, 14
Permalink
https://hdl.handle.net/2268/123974
Files (1)
Send to
Details
Statistics
Bibliography
Similar publications
Files
Full Text
Ipilimumab, un progrès significatif dans le traitement du melanome metastatique.pdf
Publisher postprint (1.15 MB)
Request a copy
All documents in ORBi are protected by a
user license
.
Send to
RIS
BibTex
APA
Chicago
Permalink
X
Linkedin
copy to clipboard
copied
Details
Keywords :
metastatic melanoma; ipilimumab; survival; CTLA-4; cutanueous adverse effects
Disciplines :
Dermatology
Author, co-author :
Libon, Florence
;
Université de Liège - ULiège > 4e an. méd.
RORIVE, Andrée
;
Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
NIKKELS, Arjen
;
Centre Hospitalier Universitaire de Liège - CHU > Dermatologie
Language :
English
Title :
L'ipilimumab, un progrès significatif dans le traitement du mélanome métastatique
Publication date :
2011
Journal title :
Skin
ISSN :
1375-1786
Publisher :
Reflexion Medical Network (RMN), Kraainem, Belgium
Special issue title :
6
Volume :
14
Available on ORBi :
since 30 May 2012
Statistics
Number of views
121 (18 by ULiège)
Number of downloads
4 (2 by ULiège)
More statistics
Bibliography
Similar publications
Contact ORBi